Your browser doesn't support javascript.
loading
4R Tau Modulates Cocaine-Associated Memory through Adult Dorsal Hippocampal Neurogenesis.
Li, Hongchun; Xu, Wei; Wang, Denian; Wang, Liang; Fang, Qiyao; Wan, Xuemei; Zhang, Jiamei; Hu, Yiming; Li, Huifang; Zhang, Jie; Yang, Zhen; Liu, Chunqi; Liu, Xiaocong; Wang, Yonghai; Liu, Bin; Hu, Zhengtao; Zhao, Ying; Bu, Qian; Wang, Hongbo; Tian, Jingwei; Zhao, Yinglan; Cen, Xiaobo.
Afiliação
  • Li H; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Xu W; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Wang D; Department of Respiratory and Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Wang L; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Fang Q; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Wan X; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Zhang J; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Hu Y; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Li H; Research Core Facility, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Zhang J; Research Core Facility, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Yang Z; Research Core Facility, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Liu C; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Liu X; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Wang Y; Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, Universities of Shandong, Yantai University, Yantai 264005, China.
  • Liu B; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Hu Z; Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, Universities of Shandong, Yantai University, Yantai 264005, China.
  • Zhao Y; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Bu Q; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Wang H; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
  • Tian J; Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, Universities of Shandong, Yantai University, Yantai 264005, China.
  • Zhao Y; Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, Universities of Shandong, Yantai University, Yantai 264005, China.
  • Cen X; National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
J Neurosci ; 41(31): 6753-6774, 2021 08 04.
Article em En | MEDLINE | ID: mdl-34099513
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas tau / Transtornos Relacionados ao Uso de Cocaína / Neurogênese / Hipocampo / Memória Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Revista: J Neurosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas tau / Transtornos Relacionados ao Uso de Cocaína / Neurogênese / Hipocampo / Memória Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Revista: J Neurosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China